Order Your Oncotect Test Today!
The world’s first non-invasive at-home cancer screening test for dogs. It is a Raleigh-based biotech startup committed to pioneering early screening of cancer risks in dogs using their urine. The company’s patent-pending in-vitro scientific test relies on its proprietary technology to detect cancerous metabolites. Oncotect is the only urine-based non-invasive, convenient, affordable, and accessible multi-cancer screening test available for dogs.
A highly accurate, non-invasive, early cancer screening tool, backed by scientific clinical research.
An advanced canine cancer screening test that enables early screening in dogs, improving treatment outcomes and offering peace of mind to pet parents through user-friendly at-home testing kits.
Non-invasive testing, requires only 2 mL of urine
With Oncotect’s non-invasive testing, no more are the days of drawing blood. One urine sample is all we need to screen the 4 most common treatable canine cancer risk.
Detect common canine cancers, fast, early & accurately.
Oncotect detects the 4 most common treatable cancers, melanoma, lymphoma, mast cell tumor, and hemangiosarcoma at 90% accuracy (83% true positive and 96% true negative), as demonstrated by clinical data.
Affordable testing makes screening accessible
Testing is made affordable to ensure parents of pets can diligently screen every 6-12 months. The DIY kit can be used at home.
Convenient
While Oncotect doesn’t require a vet visit, we keep your vet informed and involved throughout the entire process and we work closely with your vet.
Review the attached PDF to see how some vets are using the results to better understand their patient needs and outcomes!
Oncotect_-_Case_Studies.pdf (1.6 MB)